The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Selective activation of the M 1 muscarinic acetylcholine receptor achieved by allosteric potentiation
Open accessAbstract
The forebrain cholinergic system promotes higher brain function in part by signaling through the M 1 muscarinic acetylcholine receptor (mAChR). During Alzheimer's disease (AD), these cholinergic neurons degenerate, therefore selectively activating M 1 receptors could improve cognitive function in these patients while avoiding unwanted peripheral responses associated with non-selective muscarinic agonists. We describe here benzyl quinolone carboxylic acid (BQCA), a highly selective allosteric potentiator of the M 1 mAChR. BQCA reduces the concentration of ACh required to activate M 1 up to 129-fold with an inflection point value of 845 nM. No potentiation, agonism, or antagonism activity on other mAChRs is observed up to 100 μM. Furthermore studies in M 1 −/− mice demonstrates that BQCA requires M 1 to promote inositol phosphate turnover in primary neurons and to increase c-fos and arc RNA expression and ERK phosphorylation in the brain. Radioligand-binding assays, molecular modeling, and site-directed mutagenesis experiments indicate that BQCA acts at an allosteric site involving residues Y179 and W400. BQCA reverses scopolamine-induced memory deficits in contextual fear conditioning, increases blood flow to the cerebral cortex, and increases wakefulness while reducing delta sleep. In contrast to M 1 allosteric agonists, which do not improve memory in scopolamine-challenged mice in contextual fear conditioning, BQCA induces β-arrestin recruitment to M 1 , suggesting a role for this signal transduction mechanism in the cholinergic modulation of memory. In summary, BQCA exploits an allosteric potentiation mechanism to provide selectivity for the M 1 receptor and represents a promising therapeutic strategy for cognitive disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
Fredriksson, R., Lagerström, M. C., Lundin, L.-G., & Schiöth, H. B. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1256 · Cited by 2,941
Modality-Specific Retrograde Amnesia of Fear
Kim, J. J., & Fanselow, M. S. (1992) · Science · doi:10.1126/science.1585183 · Cited by 2,483
MAPK cascade signalling and synaptic plasticity
Thomas, G. M., & Huganir, R. L. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1346 · Cited by 1,454
Acetylcholine in mind: a neurotransmitter correlate of consciousness?
Perry, E., Walker, M., Grace, J., & Perry, R. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01361-7 · Cited by 763
Substitution of three amino acids switches receptor specificity of Gqα to that of Giα
Conklin, B. R., Farfel, Z., Lustig, K. D., Julius, D., & Bourne, H. R. (1993) · Nature · doi:10.1038/363274a0 · Cited by 723
Bodick, N. C., Offen, W. W., Levey, A. I., Cutler, N. R., Gauthier, S. G., Satlin, A., Shannon, H. E., Tollefson, G. D., Rasmussen, K., Bymaster, F. P., et al. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550160091022 · Cited by 692
Hansen, R. A., Webb, A. P., Moore, C. G., Gartlehner, G., Jonas, D. E., & Morgan, L. C. (2008) · PubMed · doi:10.17615/ae8c-2p76 · Cited by 673
Muscarinic acetylcholine receptors: signal transduction through multiple effectors
Felder, C. C. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.8.7768353 · Cited by 505
Marrosu, F., Portas, C., Mascia, M. S., Casu, M. A., Fà, M., Giagheddu, M., Imperato, A., & Gessa, G. L. (1995) · Brain Research · doi:10.1016/0006-8993(94)01399-3 · Cited by 480 · cited 1×
“The cholinergic system also modulates sleep; ACh levels are elevated in the cortex and hippocampus during wakefulness and REM sleep relative to slow wave delta sleep (33).”
BackgroundMiyakawa, T., Yamada, M., Duttaroy, A., & Wess, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05239.2001 · Cited by 370
Hamilton, S. E., Loose, M. D., Qi, M., Levey, A. I., Hille, B., McKnight, G. S., Idzerda, R. L., & Nathanson, N. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13311 · Cited by 366
Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology
Leach, K., Sexton, P. M., & Christopoulos, A. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.004 · Cited by 363
Levey, A. I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13541 · Cited by 359
Yamada, M., Lamping, K. G., Duttaroy, A., Zhang, W., Cui, Y., Bymaster, F. P., McKinzie, D. L., Felder, C. C., Deng, C.-X., Faraci, F. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251542998 · Cited by 275
Marino, M. J., Rouse, S. T., Levey, A. I., Potter, L. T., & Conn, P. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11465 · Cited by 275
Jones, C. K., Brady, A. E., Davis, A. A., Xiang, Z., Bubser, M., Tantawy, M. N., Kane, A. S., Bridges, T. M., Kennedy, J. P., Bradley, S. R., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1850-08.2008 · Cited by 247
Self-citationDistinct conformational changes in β-arrestin report biased agonism at seven-transmembrane receptors
Shukla, A. K., Violin, J. D., Whalen, E. J., Gesty-Palmer, D., Shenoy, S. K., & Lefkowitz, R. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804246105 · Cited by 231
Discovery of an Ectopic Activation Site on the M1Muscarinic Receptor
Spalding, T. A., Trotter, C., Skjærbæk, N., Messier, T. L., Currier, E. A., Burstein, E. S., Li, D., Hacksell, U., & Brann, M. R. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12088-3 · Cited by 193
Geula, C. (1998) · Neurology · doi:10.1212/wnl.51.1_suppl_1.s18 · Cited by 184
Fisher, A. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.002 · Cited by 174
Cellular Signaling Mechanisms for Muscarinic Acetylcholine Receptors
Lanzafame, A. A., Christopoulos, A., & Mitchelson, F. J. (2003) · Receptors and Channels · doi:10.3109/10606820308263 · Cited by 174
Bymaster, F. P., Carter, P. A., Yamada, M., Gomeza, J., Wess, J., Hamilton, S. E., Nathanson, N. M., McKinzie, D. L., & Felder, C. C. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02588.x · Cited by 167
Austin, C. P., Ky, B., Ma, L., Morris, J. A., & Shughrue, P. J. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2003.11.010 · Cited by 165
Self-citationMarlo, J. E., Niswender, C. M., Days, E., Bridges, T. M., Xiang, Y., Rodriguez, A. L., Shirey-Rice, J. K., Brady, A. E., Nalywajko, T., Luo, Q., et al. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.052886 · Cited by 159
Self-citationTargeting of Diacylglycerol Degradation to M1 Muscarinic Receptors by ß-Arrestins
Nelson, C. D., Perry, S. J., Regier, D. S., Prescott, S. M., Topham, M. K., & Lefkowitz, R. J. (2007) · Science · doi:10.1126/science.1134562 · Cited by 150
Sheffler, D. J., Williams, R. D., Bridges, T. M., Xiang, Z., Kane, A. S., Byun, N. E., Jadhav, S. B., Mock, M. M., Zheng, F., Lewis, L. M., et al. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.056531 · Cited by 143
Self-citationElhusseiny, A., Cohen, Z., Olivier, A., Stanimirovic, D. B., & Hamel, É. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199907000-00010 · Cited by 141
Allosterism at Muscarinic Receptors: Ligands and Mechanisms
Birdsall, N. J. M., & Lazareno, S. (2005) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557054023251 · Cited by 126
Rogers, J. L., & Kesner, R. P. (2004) · Learning & Memory · doi:10.1101/lm.64604 · Cited by 107
Kunapuli, P., Ransom, R. W., Murphy, K. L., Pettibone, D. J., Kerby, J., Grimwood, S., Zuck, P. D., Hodder, P., Lacson, R., Hoffman, I., et al. (2003) · Analytical Biochemistry · doi:10.1016/s0003-2697(02)00587-0 · Cited by 85
Muscarinic receptor subtypes: Modulation of ion channels
Jones, S. V. P. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90302-j · Cited by 83
Sato, A., Sato, Y., & Uchida, S. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.01.004 · Cited by 80
Muscarinic Acetylcholine Receptor Knockout Mice
Wess, J., Zhang, W., Duttaroy, A., Miyakawa, T., Gomeza, J., Cui, Y., Basile, A. S., Bymaster, F. P., McKinzie, D. L., Felder, C. C., et al. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18934-0_3 · Cited by 73
Thomas, R. L., Mistry, R., Langmead, C. J., Wood, M. D., & Challiss, R. A. J. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.141788 · Cited by 70
Yan, Y.-X., Boldt‐Houle, D. M., Tillotson, B. P., Gee, M. A., D'Eon, B. J., Chang, X.-J., Olesen, C. E. M., & Palmer, M. A. J. (2002) · SLAS DISCOVERY · doi:10.1177/108705702237677 · Cited by 59
Young, S. L., Bohenek, D. L., & Fanselow, M. S. (1995) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1995.1018 · Cited by 57
Liu, L., Zhao, R., Bai, Y., Stanish, L. F., Evans, J. E., Sanderson, M. J., Bonventre, J. V., & Rittenhouse, A. R. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2102-06.2006 · Cited by 51
Hobson, J. A., Datta, S., Calvo, J. M., & Quattrochi, J. J. (1993) · Progress in brain research · doi:10.1016/s0079-6123(08)62423-1 · Cited by 42
Sub-chronic administration of zolpidem affects modifications to rat sleep architecture
Renger, J. J., Dunn, S. L., Motzel, S. L., Johnson, C. A., & Koblan, K. S. (2004) · Brain Research · doi:10.1016/j.brainres.2004.02.067 · Cited by 37
Cited by
DeWire, S. M., Yamashita, D. S., Rominger, D. H., Liu, G., Cowan, C. L., Graczyk, T. M., Chen, X.-T., Pitis, P. M., Gotchev, D., Yuan, C., et al. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201616 · Cited by 647
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Therapeutic potential of β-arrestin- and G protein-biased agonists
Whalen, E. J., Rajagopal, S., & Lefkowitz, R. J. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.11.004 · Cited by 510
Muscarinic acetylcholine receptors: novel opportunities for drug development
Kruse, A. C., Kobilka, B. K., Gautam, D., Sexton, P. M., Christopoulos, A., & Wess, J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4295 · Cited by 437
Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs
Dror, R. O., Green, H. F., Valant, C., Borhani, D. W., Valcourt, J. R., Pan, A. C., Arlow, D. H., Canals, M., Lane, J. R., Rahmani, R., et al. (2013) · Nature · doi:10.1038/nature12595 · Cited by 411
Metadata
- Authors
- Ma, L., Seager, M. A., Wittmann, M., Jacobson, M., Bickel, D., Burno, M., Jones, K., Graufelds, V. K., Xu, G., Pearson, M., McCampbell, A., Gaspar, R., Shughrue, P., Danziger, A., Regan, C., Flick, R., Pascarella, D., Garson, S., Doran, S., Kreatsoulas, C., Veng, L., Lindsley, C. W., Shipe, W., Kuduk, S., Sur, C., Kinney, G., Seabrook, G. R., & Ray, W. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2009-09-15
- Volume
- 106
- Issue
- 37
- Pages
- 15950-15955
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2050512659
- Cited by
- 285
- References
- 40
- FWCI
- 8.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.